How to lower drug prices in the U.S.? Lots of suggestions, few viable solutions
A panel representing pharma, government payer, and policy analyst presented three potential big-picture goals to strive for.
Drug Pricing
Five things for pharma marketers to know: Monday, September 10, 2018
U.K. regulator rules MS drug too expensive; Memorial Sloan Kettering CEO demands more transparency from staff on financial relationships; Report: Family behind Purdue owns second opioid drugmaker.
Five things for pharma marketers to know: Friday, August 24, 2018
White House proposes rule for drug prices in DTC ads; FDA to study impact of side-effects warnings in drug ads; FDA approves Shire’s potential blockbuster HAE treatment.
Pfizer reorg came on heels of its walk-back on price hikes
Wednesday’s reorg was designed to position the company for growth in the face of the imminent patent cliff for megablockbuster Lyrica.
Three quarters of Americans support listing drug prices in DTC ads: Kaiser survey
Across the political spectrum, most Americans favor President Donald Trump’s proposal to show drug prices in advertisements.
